Welcome to the Kansas City Research Institute lead by liver specialist Dr. Bradley
Freilich. Dr. Freilich has over 16 years of clinical research experience in phase 2-4 hepatology and gastroenterology trials, and has
participated in close to a hundred research
trials.
Recently KCRI opened a 20 bed phase one research center. While this new facility will be able
to do studies with healthy volunteers, our specialty will be in trials for patients with liver
disease, including looking at any drug that needs to be tested in hepatic impaired
patients.
|
|
